Showing results (201-210 of 716) with videos related to

Sort By:
Pageof 72
Blood|September 23, 2006
Dasatinib (BMS-354825) is active in Philadelphia chromosome-positive chronic myelogenous leukemia after imatinib and nilotinib (AMN107) therapy failureAlfonso Quintas-Cardama, Hagop Kantarjian, Dan Jones, et al.
American Journal of Hematology|January 13, 2015
Cardiovascular and pulmonary adverse events in patients treated with BCR-ABL inhibitors: Data from the FDA Adverse Event Reporting SystemJorge Cortes, Michael Mauro, Juan Luis Steegmann, et al.
Leukemia Research|March 22, 2003
Empirical examination of the neutrophil criterion (>1500 microl(-1)) currently needed to declare CR in AMLElihu Estey, Francis Giles, Jorge Cortes, et al.
American Journal of Hematology|January 10, 2012
Characteristics of translocation (16;16)(p13;q22) acute myeloid leukemiaAlireza Eghtedar, Gautam Borthakur, Farhad Ravandi, et al.
Journal of Geriatric Oncology|July 15, 2025
Age-related disparities in survival following colorectal cancer diagnosis in an underserved community in Georgia: A retrospective cohort analysisMeng-Han Tsai, Jorge Cortes, Elinita Pollard, et al.
Leukemia & Lymphoma|April 12, 2013
Splenectomy in patients with myeloproliferative neoplasms: efficacy, complications and impact on survival and transformationFabio P S Santos, Constantine S Tam, Hagop Kantarjian, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 29, 2017
Sepsis and Acute Myeloid Leukemia: A Population-Level Study of Comparative Outcomes of Patients Discharged From Texas HospitalsImrana A Malik, Marylou Cardenas-Turanzas, Susan Gaeta, et al.
Leukemia Research|February 18, 2015
Increased likelihood of post-polycythemia vera myelofibrosis in Ph-negative MPN patients with chromosome 12 abnormalitiesChristopher B Benton, Maria Tanaka, Catherine Wilson, et al.
Cancer|June 16, 2004
Granulocyte-colony-stimulating factor (filgrastim) may overcome imatinib-induced neutropenia in patients with chronic-phase chronic myelogenous leukemiaAlfonso Quintas-Cardama, Hagop Kantarjian, Susan O'Brien, et al.
Cancer|May 26, 2004
Erythropoietin is effective in improving the anemia induced by imatinib mesylate therapy in patients with chronic myeloid leukemia in chronic phaseJorge Cortes, Susan O'Brien, Alfonso Quintas, et al.
Pageof 72